WIX reports Q1 results on May 20 — a week away — and the set-up carries a clear tension: short sellers have been covering hard since mid-April, yet sell-side targets remain well above where the stock is trading, and the most recent action from JP Morgan landed this morning as a lowered price target under an Underweight rating.
The short interest story has moved fast in both directions. Borrowers piled in through mid-April, pushing estimated short interest to just over 11 million shares — around 20% of free float — before a sharp unwind began. By May 12 the position had fallen to roughly 7.7 million shares, or 14.1% of the float. That is still a meaningful short book relative to the broader market, but the drop of nearly 9.5% over the past week signals active covering rather than new conviction. The borrow market reinforces this read. Cost to borrow has collapsed from above 7% in early April to just 0.66% — extremely cheap — and availability is comfortable, meaning there is no mechanical squeeze pressure building ahead of the print. The ORTEX short score of 68.4 remains elevated but has eased slightly from highs above 69.8 a week ago.
Options positioning is neutral, almost to the point of being uninformative. The put/call ratio of 0.89 is fractionally below its 20-day average of 0.92, placing it essentially flat on a z-score basis at -0.25. There is no discernible rush for protection ahead of earnings — a notable contrast given the stock fell 4.3% on May 12 alone. The PCR has come down steadily from readings just above 1.0 in late April and early May, suggesting calls are being added or put hedges are being lifted. Either way, the options market is not pricing an outsized move in either direction.
The Street is cautious but not panicked. JP Morgan today cut its target to $86 — still above the current $75.88 close — while maintaining an Underweight. That move follows BofA trimming its Buy target to $109 in late April, Oppenheimer lowering its Outperform target to $115, and UBS downgrading outright to Neutral in early April. Barclays held its Overweight but cut to $155. The pattern is consistent: firms are maintaining broadly positive ratings but compressing their targets sharply as macro uncertainty weighs on growth multiples. The mean analyst target is $111.32, implying roughly 47% upside from current levels — a gap that reflects either deep Street optimism or a stock that has overshot to the downside. The forward EPS momentum score of 86 out of 100 suggests estimate revisions have been running upward, but the 90-day version of the same metric drops to just 27, pointing to a recent deceleration in that trend.
The institutional picture adds a notable subplot. Millennium Management added roughly 2.4 million shares in Q1, bringing its holding to just over 3 million shares — 5.2% of outstanding. HSBC Global Asset Management entered as a new major holder with nearly 3.6 million shares, adding essentially the entire position in the quarter. Columbia Management remains the largest institutional holder at 10.3% of shares, having added over 1.1 million shares. Against this accumulation from large institutional names, the bear case centres on AI disruption risk to legacy web-creation platforms and slowing subscription growth. The bull case points to the Base44 business solutions unit, with ARR projected to reach $100 million in Q1, and continued strength in partner revenue through the Wix Studio platform.
The one concrete earnings-reaction data point available is striking. After the most recent comparable print, the stock surged 25% on the day and held 20.9% of that gain through the following week. That reaction came in early March 2026 — likely the Q4 2025 report — and it resets the baseline for what a positive surprise can do. With SI still at 14% of free float and a meaningful short book yet to be fully covered, a strong Q1 number on May 20 carries the same mechanical potential. What to watch: whether Q1 ARR from Base44 hits the $100 million projection, whether gross margins show the stabilisation the bulls need, and how management characterises AI's net impact — as headwind or product opportunity.
See the live data behind this article on ORTEX.
Open WIX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
